Fabri; Louis Jerry

Patent Applications and Registrations

Patent applications and USPTO patent grants for Fabri; Louis Jerry.The latest application filed is for "antibody molecule for human gm-csf receptor alpha".

Company Profile

5.17.18

Fabri; Louis Jerry - Diamond Creek AU
Fabri; Louis Jerry - Victoria N/A AU

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Antibody Molecule For Human Gm-csf Receptor Alpha App 20210147559 - Cohen; Emma Suzanne ; et al.	2021-05-20
Antibody Molecule For Human Gm-csf Receptor Alpha App 20190309077 - Cohen; Emma Suzanne ; et al.	2019-10-10
Antibody Molecule For Human Gm-csf Receptor Alpha App 20190040145 - Cohen; Emma Suzanne ; et al.	2019-02-07
High affinity antibody antagonists of interleukin-13 receptor alpha 1 Grant 10,106,617 - Nash , et al. October 23, 2	2018-10-23
High Affinity Antibody Antagonists Of Interleukin-13 Receptor Alpha 1 App 20170369579 - Nash; Andrew Donald ; et al.	2017-12-28
High affinity antibody antagonists of interleukin-13 receptor alpha 1 Grant 9,777,062 - Nash , et al. October 3, 2	2017-10-03
High Affinity Antibody Antagonists Of Interleukin-13 Receptor Alpha 1 App 20160362497 - Nash; Andrew Donald ; et al.	2016-12-15
High affinity antibody antagonists of interleukin-13 receptor alpha 1 Grant 9,371,388 - Nash , et al. June 21, 2	2016-06-21
Antibody Molecule For Human GM-CSF Receptor Alpha App 20150376285 - Cohen; Emma Suzanne ; et al.	2015-12-31
Antibody molecule for human GM-CSF receptor alpha Grant 9,085,628 - Cohen , et al. July 21, 2	2015-07-21
Method Of Treating Cancer Comprising A Vegf-b Antagonist App 20140363445 - Nash; Andrew ; et al.	2014-12-11
Method of treating cancer comprising a VEGF-B antagonist Grant 8,822,644 - Nash , et al. September 2, 2	2014-09-02
Antibody Molecule For Human Gm-csf Receptor Alpha App 20140079708 - Cohen; Emma Suzanne ; et al.	2014-03-20
High Affinity Antibody Antagonists Of Interleukin-13 Receptor Alpha 1 App 20140056915 - Nash; Andrew Donald ; et al.	2014-02-27
Anti-IL-13R.alpha.1 antibodies and their uses thereof Grant 8,613,925 - Nash , et al. December 24, 2	2013-12-24
High affinity antibody antagonists of interleukin-13 receptor alpha 1 Grant 8,568,722 - Nash , et al. October 29, 2	2013-10-29
Antibody molecule for human GM-CSF receptor alpha Grant 8,506,960 - Cohen , et al. August 13, 2	2013-08-13
Antibody molecule for human GM-CSF receptor alpha Grant 8,263,075 - Cohen , et al. September 11, 2	2012-09-11
Monoclonal antibody against interleukin-13 receptor alpha 1 (IL-13Ralpha1) Grant 8,221,755 - Dunlop , et al. July 17, 2	2012-07-17
Antibody antagonists of interleukin-13 receptor .alpha.1 Grant 8,207,304 - Nash , et al. June 26, 2	2012-06-26
Binding Member For Gm-csf Receptor App 20120141464 - Cohen; Emma Suzanne ; et al.	2012-06-07
Anti-IL-13R Alpha1 Antibodies and Their Uses Thereof App 20110052597 - Nash; Andrew Donald ; et al.	2011-03-03
Monoclonal Antibody Against Interleukin-13 Receptor Alpha 1 (il-13ralpha1) App 20110020363 - DUNLOP; Felicity Meredith ; et al.	2011-01-27
High Affinity Antibody Antagonists of Interleukin-13 Receptor Alpha 1 App 20100285035 - Nash; Andrew Donald ; et al.	2010-11-11
Monoclonal antibody against interleukin-13 receptor alpha 1 (IL-13Ra1) Grant 7,785,590 - Dunlop , et al. August 31, 2	2010-08-31
High affinity antibody antagonists of interleukin-13 receptor alpha 1 Grant 7,754,213 - Nash , et al. July 13, 2	2010-07-13
Antibody Antagonists of Interleukin-13 Receptor Alpha1 App 20090285799 - Nash; Andrew Donald ; et al.	2009-11-19
Binding Member For Gm-csf Receptor App 20090130093 - Cohen; Emma Suzanne ; et al.	2009-05-21
Method of Treating Cancer Comprising a Vegf-B Antgonist App 20080260729 - Nash; Andrew ; et al.	2008-10-23
High affinity antibody antagonists of interleukin-13 receptor alpha 1 App 20080166343 - Nash; Andrew Donald ; et al.	2008-07-10
Monoclonal antibody against Interleukin-13 receptor alpha 1 (IL-13Ralpha1) App 20050058645 - Dunlop, Felicity Meredith ; et al.	2005-03-17

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.